engleski

Lung in idiopathic inflammatory myopathies

Lung involvement is frequent in patients with idiopathic inflammatory myopathies. The most common manifestations are diverse parenchymal diseases, interstitial lung diseases, infections, and hypoventilation respiratory failure due to weakness of respiratory muscle. The clinical picture may be acute in need of treatment in intensive care unit, or it can show slow progressive course. Therapy of ILD in patients with IIM is of utmost importance for their outcome and the survival. There are no controlled studies because myositis is a rare disease, and pulmonary interstitial manifestations even rarer. The corticosteroid and other immunosuppressive agents, methotrexate, cyclophosphamide and azathiprine are used with sufficient efficacy in most cases.

Inflammatory myopathies, pulmonary manifestations

nije evidentirano